| RS1064793637 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1064793639 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1064793642 |
MYBPC3
|
Health Risk |
Pathogenic |
— |
| RS1064793643 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS1064793644 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1064793645 |
AR
|
Health Risk |
Pathogenic |
— |
| RS1064793646 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1064793649 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS1064793651 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1064793655 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1064793656 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1064793657 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1064793658 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1064793660 |
NOTCH2
|
Health Risk |
Pathogenic |
— |
| RS1064793662 |
ACSF3
|
Health Risk |
Pathogenic |
Methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS1064793663 |
PIK3CA
|
Health Risk |
Pathogenic |
Global developmental delay, Hypospadias |
| RS1064793664 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1064793665 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS1064793668 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1064793671 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1064793672 |
MEN1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1064793673 |
B3GALNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS1064793674 |
LMNA
|
Health Risk |
Pathogenic |
— |
| RS1064793675 |
FLG
|
Health Risk |
Pathogenic |
— |
| RS1064793677 |
ADNP
|
Health Risk |
Pathogenic |
— |
| RS1064793678 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1064793679 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793681 |
SNX14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive spinocerebellar ataxia 20, Autosomal recessive spinocerebellar ataxia 20 |
| RS1064793682 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1064793683 |
SLC25A15
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS1064793684 |
EDAR
|
Health Risk |
Pathogenic |
— |
| RS1064793685 |
GLI3
|
Health Risk |
Pathogenic |
— |
| RS1064793686 |
RPL5
|
Health Risk |
Pathogenic |
— |
| RS1064793688 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast carcinoma, Hereditary nonpolyposis colorectal neoplasms |
| RS1064793691 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1064793692 |
IQCB1
|
Health Risk |
Pathogenic |
— |
| RS1064793693 |
TSC1
|
Health Risk |
Pathogenic |
— |
| RS1064793695 |
ABCA12
|
Health Risk |
Pathogenic |
— |
| RS1064793698 |
PTCH1
|
Health Risk |
Pathogenic |
— |
| RS1064793703 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS1064793704 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793705 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS1064793707 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS1064793709 |
PRKAR1A
|
Health Risk |
Pathogenic |
— |
| RS1064793712 |
PRKAR1A
|
Health Risk |
Pathogenic |
— |
| RS1064793714 |
MKKS
|
Health Risk |
Pathogenic |
— |
| RS1064793715 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793716 |
APC
|
Health Risk |
Likely pathogenic |
Carcinoma of colon, Hereditary cancer-predisposing syndrome |
| RS1064793717 |
RYR1
|
Health Risk |
Pathogenic |
— |
| RS1064793721 |
KAT6A
|
Health Risk |
Pathogenic |
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS1064793722 |
SCN8A
|
Health Risk |
Pathogenic |
— |
| RS1064793723 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS1064793724 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793729 |
CNKSR2
|
Health Risk |
Pathogenic |
— |
| RS1064793730 |
MEF2C
|
Health Risk |
Pathogenic |
— |
| RS1064793731 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Familial isolated arrhythmogenic right ventricular dysplasia |
| RS1064793732 |
PIK3CA
|
Health Risk |
Pathogenic |
Cowden syndrome, Ovarian neoplasm |
| RS1064793733 |
CEP290
|
Health Risk |
Pathogenic |
— |
| RS1064793734 |
ENG
|
Health Risk |
Pathogenic |
Hereditary hemorrhagic telangiectasia, Cardiovascular phenotype |
| RS1064793735 |
DCX
|
Health Risk |
Pathogenic |
— |
| RS1064793739 |
POLR3B
|
Health Risk |
Pathogenic |
— |
| RS1064793741 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Fumarase deficiency, Hereditary cancer-predisposing syndrome |
| RS1064793742 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1064793743 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1064793745 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1064793746 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064793747 |
VPS13B
|
Health Risk |
Pathogenic |
— |
| RS1064793748 |
EHMT1
|
Health Risk |
Pathogenic |
— |
| RS1064793749 |
RHO
|
Health Risk |
Likely pathogenic |
Autosomal dominant retinitis pigmentosa, Autosomal dominant retinitis pigmentosa |
| RS1064793753 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1064793755 |
OPHN1
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability-cerebellar hypoplasia syndrome, Thyroid cancer |
| RS1064793756 |
GATAD2B
|
Health Risk |
Pathogenic |
— |
| RS1064793757 |
BTD
|
Health Risk |
Pathogenic |
— |
| RS1064793758 |
FANCB
|
Health Risk |
Pathogenic |
— |
| RS1064793759 |
KMT2C
|
Health Risk |
Pathogenic |
— |
| RS1064793760 |
COL17A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS1064793761 |
PURA
|
Health Risk |
Pathogenic |
— |
| RS1064793762 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1064793763 |
NHEJ1
|
Health Risk |
Pathogenic |
Cernunnos-XLF deficiency, Cernunnos-XLF deficiency |
| RS1064793765 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1064793766 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS1064793767 |
NDUFAF1
|
Health Risk |
Pathogenic |
— |
| RS1064793768 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS1064793769 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1064793770 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS1064793771 |
SBF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4, SBF2-related disorder |
| RS1064793772 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064793778 |
APC
|
Health Risk |
Pathogenic |
— |
| RS1064793779 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1064793780 |
CHEK2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1064793781 |
MSH6
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Endometrial carcinoma |
| RS1064793786 |
EXT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1064793789 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1064793791 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS1064793792 |
SERPING1
|
Health Risk |
Pathogenic |
— |
| RS1064793795 |
COG4
|
Health Risk |
Likely pathogenic |
— |
| RS1064793796 |
DDX3X
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked 102 |
| RS1064793797 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1064793799 |
LDLR
|
Health Risk |
Likely pathogenic |
LDLR-related disorder, LDLR-related disorder |
| RS1064793800 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |